Chemomab Therapeutics Ltd.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $7.6M | $6.1M | $9.3M | $13.5M | $15.2M | $11.7M | $17.6M | $7.5M |
| Accounts Receivable | — | — | — | — | — | — | $408.0K | $3.4M |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $13.4M | $16.0M | $20.9M | $41.7M | $62.7M | $11.8M | $18.2M | $10.9M |
| Property, Plant & Equipment | $176.0K | $250.0K | $303.0K | $367.0K | $357.0K | $152.0K | $158.0K | $385.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $13.8M | $17.0M | $22.2M | $43.1M | $64.4M | $12.5M | $19.8M | $12.8M |
| Liabilities | ||||||||
| Accounts Payable | $485.0K | $633.0K | $516.0K | $1.7M | $1.3M | $93.0K | $875.0K | $396.0K |
| Total Current Liabilities | $1.5M | $3.2M | $4.8M | $6.7M | $2.7M | $1.3M | $4.1M | $2.7M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $1.5M | $3.4M | $5.2M | $6.8M | $2.9M | $1.7M | $4.8M | $3.0M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-111.6M | $-102.6M | $-88.7M | $-63.8M | $-36.2M | $-23.7M | $-105.4M | $-78.3M |
| Total Stockholders' Equity | $12.3M | $13.5M | $17.0M | $36.2M | $61.5M | $10.8M | $12.4M | $9.8M |